Literature DB >> 23568120

Nitrous oxide does not depress left ventricular contractility in ischemic rat heart.

E Inada1, M D'Ambra, P J Laraia, D M Philbin, M J Buckley.   

Abstract

The direct effects of nitrous oxide on left ventricular contractility and myocardial oxygen consumption (MVO2) in the ischemic isolated rat heart were studied. The rat heart was isolated and perfused by a Langendorf technique. The aortic stump was cannulated and the heart was perfused with Kumpeis solution bubbled with 95% O2 and 5% CO2 (control phase). A latex balloon was inserted into the left ventricle (LV) to measure LV pressures and dP/dt. Coronary flow was measured and MVO2 was calculated. After the control phase, perfusion pressure was decreased to induce global ischemia (ischemic phase). There were four groups of eight hearts each: control, nitrogen, nitrous oxide, and halothane groups. After 15 min of ischemic phase, the perfusion pressure was increased and the gas mixture was changed to the standard gas mixture (reperfusion phase). Nitrous oxide did not further depress myocardial contractility compared with nitrogen in the ischemic phase, and did not alter MVO2 in the ischemic phase compared with nitrogen. Halothane significantly depressed myocardial contractility and decreased MVO2 in the ischemic phase compared with the control.

Entities:  

Year:  1994        PMID: 23568120     DOI: 10.1007/BF02514658

Source DB:  PubMed          Journal:  J Anesth        ISSN: 0913-8668            Impact factor:   2.078


  16 in total

1.  Cardiovascular effects of 40 percent nitrous oxide in man.

Authors:  J H Eisele; N T Smith
Journal:  Anesth Analg       Date:  1972 Nov-Dec       Impact factor: 5.108

2.  Nitrous oxide worsens myocardial ischemia in isoflurane-anesthetized dogs.

Authors:  H J Nathan
Journal:  Anesthesiology       Date:  1988-03       Impact factor: 7.892

3.  Nitrous oxide does not induce myocardial ischemia in patients with ischemic heart disease and poor ventricular function.

Authors:  M M Mitchell; O Prakash; E N Rulf; M E van Daele; M K Cahalan; J R Roelandt
Journal:  Anesthesiology       Date:  1989-10       Impact factor: 7.892

4.  Myocardial performance and N2O analgesia in coronary-artery disease.

Authors:  J H Eisele; J A Reitan; R A Massumi; R F Zelis; R R Miller
Journal:  Anesthesiology       Date:  1976-01       Impact factor: 7.892

5.  Nitrous oxide augments the systemic and coronary haemodynamic effects of isoflurane in patients with ischaemic heart disease.

Authors:  S Reiz
Journal:  Acta Anaesthesiol Scand       Date:  1983-12       Impact factor: 2.105

6.  Addition of nitrous oxide to fentanyl anesthesia does not induce myocardial ischemia in patients with ischemic heart disease.

Authors:  M K Cahalan; O Prakash; E N Rulf; M T Cahalan; A P Mayala; F C Lurz; P Rosseel; E Lachitjaran; K Siphanto; E J Gussenhoven
Journal:  Anesthesiology       Date:  1987-12       Impact factor: 7.892

7.  Nitrous oxide added to halothane reduces coronary flow and myocardial oxygen consumption in patients with coronary disease.

Authors:  E A Moffitt; D H Sethna; R J Gary; M J Raymond; J M Matloff; J A Bussell
Journal:  Can Anaesth Soc J       Date:  1983-01

8.  Hemodynamic effects of nitrous oxide administered during cardiac catheterization.

Authors:  J Wynne; T Mann; J S Alpert; L H Green; W Grossman
Journal:  JAMA       Date:  1980-04-11       Impact factor: 56.272

9.  Postsystolic shortening of canine left ventricle supplied by a stenotic coronary artery when nitrous oxide is added in the presence of narcotics.

Authors:  D M Philbin; P Föex; G Drummond; E Lowenstein; W A Ryder; L A Jones
Journal:  Anesthesiology       Date:  1985-02       Impact factor: 7.892

10.  Cardiovascular responses to nitrous oxide exposure for two hours in man.

Authors:  R Kawamura; T H Stanley; J B English; G E Hill; W S Liu; L R Webster
Journal:  Anesth Analg       Date:  1980-02       Impact factor: 5.108

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.